Clinical trial Recruiting at 1 site Observational Ages 8 to 18

How insomnia affects PAP use in children and teens with obstructive sleep apnea.

Official title: The IPAD Cohort Study: Insomnia and Positive Airway Pressure Adherence in Children and Adolescents

Run by University of British Columbia · NCT07176767 · Data updated 2026-11-12

This study will see if insomnia makes children and teens with obstructive sleep apnea less likely to stick with positive airway pressure (PAP) therapy.

Quick facts

Study typeObservational
Ages8 Years to 18 Years
SexAll
Enrollment82 (estimated)
SponsorUniversity of British Columbia
Academic / other
Locations1 site (Vancouver, British Columbia)
StatusRecruiting
StartedJune 12, 2025
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedSeptember 23, 2025
Trial IDNCT07176767 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children 8–18 with obstructive sleep apnea (AHI ≥ 5/hour) who are newly prescribed PAP therapy and can complete questionnaires.

Probably not a fit

Children under 8, those already using PAP, those with developmental disabilities that prevent answering questionnaires, or those with primarily non-obstructive sleep disorders may not receive benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter observational cohort will follow 82 children aged 8–18 with obstructive sleep apnea who are newly prescribed PAP therapy at two Canadian pediatric hospitals. Participants will complete insomnia and sleep questionnaires and have objective PAP usage data collected over time to measure adherence. The study will analyze whether insomnia symptoms predict lower PAP use and whether race or ethnicity influence adherence patterns. The longitudinal design is intended to clarify temporal relationships between insomnia and PAP adherence in pediatric patients.

Why it matters

Potential benefit: If successful, the study could identify insomnia as a treatable factor to improve PAP use and sleep outcomes for children with OSA.

How similar studies have gone: Adult studies have shown that treating insomnia can improve PAP adherence, but longitudinal data in pediatric populations are novel and unproven.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Children aged 8-18 years old
2. Obstructive apnea-hypopnea index ≥ 5/hour on baseline diagnostic polysomnogram (PSG)
3. Newly prescribed PAP therapy

Exclusion Criteria:

1\) Developmental disability precluding ability to answer questionnaires

Where it's running

  • British Columbia Children's Hospital
    Vancouver, British Columbia, Canada
    Recruiting

Study contacts

  • Principal investigator: Lena J Xiao, MD, MSc — Provincial Health Services Authority British Columbia
  • Study coordinator: Lena J Xiao, MD MSc
  • Email: lena.xiao@cw.bc.ca
  • Phone: 6048752345

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.